Literature DB >> 26169998

Anatomical preconditions for the palatal sinus floor augmentation—A three-dimensional feasibility study.

F Wagner1, G Dvorak2, R Pillerstorff1, H Traxler3, S Nemec4, P Pietschmann5, R Seemann1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the anatomical feasibility of palatal sinus floor augmentation.
MATERIAL AND METHODS: In 100 men and 100 women, both sinuses were analyzed using computed tomography. The patients were divided into four anatomical groups according to the remaining alveolar bone height: group 1 (0 ≤ × < 4), group 2 (4 ≤ × < 8), group 3 (8 ≤ × < 12), and group 4 (≥12).
RESULTS: The 400 maxillary sinuses consisted of 23.5% (n = 94) group 1, 42.75% (n = 171) group 2, 23.5% (n = 98) group 3, and 9.25% (n = 37) group 4 sinuses. Optimal anatomical preconditions for palatal sinus floor augmentations (i.e., ≥5 mm height and <5 mm thickness of the window lid) were found in 93.6% of group 1 sinuses, 73.7% of group 2 sinuses, 23.5% of group 3 sinuses, and 5.4% of group 4 sinuses.
CONCLUSION: The palatal approach is feasible in 93.6% of patients with remnant alveolar height of up to 4 mm. Limitations are alveolar heights of ≤5 mm as well as great palatal thickness and thus limited dimensions for a possible palatal window.
Copyright © 2015 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveolar bone atrophy; Bone regeneration; Dental implants; Maxillary sinus; Preprosthetic oral surgical procedure; Sinus floor augmentation

Mesh:

Substances:

Year:  2015        PMID: 26169998     DOI: 10.1016/j.jcms.2015.06.004

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  1 in total

1.  Morphometric analysis of sinus depth in the posterior maxilla and proposal of a novel classification.

Authors:  Florian Wagner; Gabriella Dvorak; Stefan Nemec; Peter Pietschmann; Hannes Traxler; Kurt Schicho; Rudolf Seemann
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.